Recent News


University of Alabama takes a Dogged Approach to Precision Medicine

April 19, 2018
Learn how the University of Alabama is taking a dogged approach to studying new brain tumor therapies.
Read More

PierianDx Forms Strategic Partnership with Leading Research and Technical Services Organization RTI International

April 17, 2018
PierianDx, the leading genomics technology companythat enables precision medicine,announced today a strategic partnership with RTI International to help solve the problem
Read More

Optimizing the Bioinformatics Output of your Molecular Pathology Lab

April 13, 2018
We have a lot to gain from accelerating the adoption of NGS testing. The technology exists, but that's only half the battle. The right approach matters too. Learn more by attending our informative webinar on April 24.
Read More

PierianDx Showcases Germline Capabilities of its Clinical Genomics WorkSpace™ (CGW) Platform at ACMG 2018

April 12, 2018
PierianDx, the leading genomics technology company that enables precision medicine, announced today at the annual meeting of the American College of
Read More

PierianDx Names Chris Callahan as Chief Commercial Officer to Drive Expansion of its Genomics Technology Platform for Clinical Labs

April 11, 2018
PierianDx named Chris Callahan as the new Chief Commercial Officer to accelerate adoption and expansion of the company’s enterprise informatics
Read More

Cardiology Field Whole-heartedly Ready for Precision Medicine

April 10, 2018
Learn how cardiologists are bringing precision medicine to their patients.
Read More

PierianDx Announces TriCore Reference Laboratories as the Newest Customer to its Partner Sharing Network

April 6, 2018
Learn how TriCore Reference Laboratories will use the Clinical Genomics WorkSpace (CGW) from PierianDx to accelerate NGS testing.
Read More

All of Us Initiative: Highlighting the Need for Streamlined Genetic Analysis

April 6, 2018
Learn more about All of Us, the landmark study being launched by the NIH, and why we need solutions for streamlining genetic analysis.
Read More

Inova Launches Predictive Phenotyping Study with NIH

April 5, 2018
Learn more about the predictive phenotyping study being launched by Inova and the NIH.
Read More

PierianDx to Unveil Blueprint for Bringing Next Generation Sequencing (NGS) Testing In-house at Executive War College

April 3, 2018
The drive to deliver precision medicine has galvanized many hospitals to in-source next generation sequencing (NGS) testing. Working with our customers, we've established some best practices and will discuss them at the upcoming Executive War College.
Read More

Identifying Disease Risks Associated with Premature Mortality: A Study from Human Longevity

March 28, 2018
Find out how PierianDx customer, HLI, is using genomic data to help understand age-induced disease.
Read More

A Precision Medicine Approach for Rheumatoid Arthritis Patients

March 27, 2018
Learn how doctors at Northwestern are taking a precision medicine-based approach to treat patients with rheumatoid arthritis.
Read More

PierianDx Customer, Moffitt Cancer Center, Launches Clinical NGS Assay, STAR

March 26, 2018
The Moffitt Morsani Molecular Laboratory, located within the Moffitt Cancer Center, announced today that it has launched a new clinical
Read More

PierianDx Showcases Germline Features in CGW at ACMG 2018

March 26, 2018
Want to learn more about how our technology and services can address the complexity and scale of your genomics? Then visit us at the upcoming ACMG annual meeting in Charlotte, North Carolina.
Read More

CMS Final Coverage Decision for NGS: a Victory for Lab Developed Tests and Cancer Patients

March 23, 2018
Learn more about the recent coverage decision and what it means for Laboratory Developed Tests and Cancer Patients.
Read More

Precision Medicine in Canada

March 20, 2018
How does Canada fare in the campaign to bring precision medicine to patients? Read our blog to learn more, and find out about some of the initiatives currently underway.
Read More

PierianDx to Participate in 2nd International Precision Oncology and Experimental Therapeutics ‘POET’ Congress in Canada

March 16, 2018
On April 5 and 6 oncology leaders will convene in Calgary, Alberta to participate in the 2nd International Precision Oncology
Read More
Newborn baby

Saving Infants with Genetic Testing

March 16, 2018
Rady's Children's Hospital performs whole genome sequencing to rapidly diagnose and treat newborns.
Read More
radiologist examining x-ray of lungs

PierianDx Customer Dartmouth-Hitchcock Medical Center Illustrates ALK-Rearranged Lung Cancer Patient Case in CAP Today Article

March 16, 2018
Learn more about ALK-rearranged lung cancer from the important work done at Dartmouth University.
Read More
Patient wearing ID band holding provider's hand

Precision Medicine to Improve Patient Safety

March 15, 2018
It's National Patient Safety Week. Learn how precision medicine directly impacts the care that patients receive.
Read More

HIMSS18 Round-up: Why the Time for Precision Medicine is Now

March 14, 2018
Key takeaways from HIMSS18 reinforce how important it is to build foundations for precision medicine now.
Read More

PierianDx Announces Partnership with Cancer Genetics to Provide Comprehensive Precision Oncology Testing and Workflow Solution

March 14, 2018
PierianDx, the leading genomics technology company that enables precision medicine programs and molecular testing for healthcare organizations, announced today a partnership
Read More

PierianDx Launches Clinical Genomics Services to Accelerate Precision Medicine

March 8, 2018
PierianDx, the leading genomics technology company that enables precision medicine, announced today a full range of expanded services to support adoption
Read More
Philadelphia-One-Day-Summit-min

PierianDx Exhibiting at Health Systems Summit

February 18, 2018
PierianDx will be exhibiting at an intensive one-day summit for CEOs and hospital administrators of health systems. “Precision Medicine for
Read More

PierianDx Hosts Expert Customer Panel Discussion Regarding Debated CMS National Coverage Decision on NGS Testing

February 13, 2018
PierianDx, the leading genomics technology company that enables precision medicine programs and molecular testing for healthcare organizations, announced today it will
Read More

PharmaTech Outlook Spotlights PierianDx in December Issue

January 5, 2018
PharamTech Outlook recently featured PierianDx in it’s December 2017 issue, outlining the groundbreaking role the company has played in advancing
Read More

PierianDx Names New Additions to Sales and Clinical Genomic Solutions Teams

October 26, 2017
PierianDx announced today two key additions that will expand the organization’s reach into health systems and global markets while deepening
Read More

Cleveland Clinic Joins PierianDx’s Customer Network to Accelerate Precision Medicine

October 17, 2017
PierianDx announced today that Cleveland Clinic will utilize its integrated “one space” workflow and analysis solution, Clinical Genomicist Workspace (CGW),
Read More

PierianDx Accelerates Precision Medicine with Fully Integrated Workflow and Interpretation Solution Supporting Illumina TruSight Tumor 170

October 11, 2017
PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, announced today it has launched a complete technology and medical
Read More

PierianDx Announces Clinical Microarray Technology Will Be Integrated into its End-to- End Genomics Platform for Clinical Labs

September 21, 2017
ST LOUIS  – PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, announced that its leading, integrated “one space” genomics workflow
Read More

Moffitt Cancer Center Showcases its Blueprint for Building a Best-in-Class Precision Medicine Program at PierianDx-hosted Webinar

September 11, 2017
PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, will host a webinar featuring Moffitt Cancer Center’s journey to
Read More

PierianDx Announces Launch of Clinical Interpretation Services at ACMG 2017

March 23, 2017
New Service Combines Powerful Technology with Medical and Scientific Expertise PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, announced
Read More

PierianDx Customers Cite ‘Creative Partnership’ on Clinical Genomics as Key Selling Point

March 13, 2017
NEW YORK (GenomeWeb) – Last week, PierianDx announced six new customers for its Clinical Genomicist Workspace (CGW), including Cedars-Sinai Medical
Read More

PierianDx’s Partner Sharing Network Achieves Critical Mass with New Wave of Customers Adopting Clinical Genomicist Workspace (CGW)

March 3, 2017
PierianDx announced today that six leading healthcare systems and academic medical centers have chosen its leading “One Space” genomics software
Read More

University of Vermont Touts the Importance of Clinical Integration to Accelerate Precision Medicine in PierianDx Webinar Series

February 28, 2017
PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, announced today its latest online webinar entitled, “Accelerating Your NGS
Read More

Doctors Use Computers More and Microscopes Less to Find Future Cancer Treatments

December 6, 2016
Not long ago, doctors hoping to cure human disease spent a lot of time in the laboratory looking through microscopes.
Read More

PierianDx Acquires Tute Genomics

October 11, 2016
Company Extends Ability to Deliver a Unified Sample-to-Report Software Platform for Clinical Labs PierianDx, the forerunner in clinical genomic analysis, interpretation
Read More

PierianDx Named to CIOReview’s 20 Most Promising Cloud Solution Providers 2016

August 30, 2016
ST LOUIS – PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, was recently included in a list of
Read More

PierianDx and ArcherDX Announce Partnership Benefiting NGS Clinical Labs

July 19, 2016
ST LOUIS/BOULDER – ArcherDX and PierianDx today announced co-marketing and licensing agreements that will provide enhanced NGS testing capabilities to
Read More

PierianDx Announces 10 New Customers in Q1 2016, Expands Partner Sharing Network to 24 Members

April 28, 2016
ST. LOUIS, MO  – PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, announced it has added several new
Read More

PierianDx Announces Two New Board Members; Bryan Carey and Frederick Hessler Bring Vast Healthcare Experience

March 22, 2016
ST LOUIS, MO – PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, announced that Bryan J. Carey and
Read More

PierianDx Closes Series A Financing Led by Health Catalyst Capital Management; Company Poised for Next Stage of Growth

January 7, 2016
PierianDx, the leading provider of genomic software and services to enable data-driven personalized medicine, announced that it closed $9.25 million in Series A financing
Read More

PierianDx and Syapse Partner to Accelerate Precision Medicine Programs for Healthcare Providers

October 29, 2015
ST. LOUIS, MO and PALO ALTO, CA – PierianDx, makers of the leading bioinformatics platform for clinical genomics testing, and
Read More

Aeon Clinical Laboratories Leverages PierianDx Bioinformatics Platform to Enhance Genomic Test Offering

October 13, 2015
ST LOUIS, MO/GAINSVILLE, GA – PierianDx, the forerunner in clinical genomic informatics, and Aeon Clinical Laboratories, one of the fastest
Read More

MDL Partners with PierianDx to Rapidly Launch Next Generation Sequencing Tests for Breast Cancer

August 25, 2015
ST LOUIS, MO – PierianDx, the forerunner in clinical genomic informatics, announced today that Molecular Diagnostics Laboratories (MDL) has standardized
Read More

PierianDx Launches Exome Next Generation Sequencing Offering; Leading Medical Experts Shape Platform Functionality

August 13, 2015
ST LOUIS, MO – PierianDx, the forerunner in clinical genomic informatics, announced today that it has released a new version
Read More

PierianDx Builds Leadership Team to Accommodate Fast Growth Jim Howard Joins as Senior VP Sales

April 23, 2015
ST LOUIS, MO – PierianDx, the forerunner in clinical genomic informatics, announced today that healthcare entrepreneur Jim Howard is joining
Read More

PierianDx Plans Software Update to Improve Variant Prioritization, Clinical Relevance Assessment

April 2, 2015
NEW YORK (GenomeWeb) – This summer, PierianDx plans to add a so-called PDx score to the next iteration of Clinical
Read More

PierianDx Introduces PDx Score to Quickly Prioritize Actionable Variants, While Expanding Industry-Leading Knowledgebase

March 24, 2015
ST LOUIS, MO –  PierianDx announced today that its genomic testing platform will soon produce a PDx Score giving clinicians
Read More

UVA to use PierianDx Platform to Analyze, Report on Cancer Patients’ Genome Data

February 23, 2015
ST LOUIS, MO and CHARLOTTESVILLE, VA – PierianDx announced today that the University of Virginia Health System has joined the
Read More

Inova Joins PierianDx Partner Network to Provide Precision Medicine to Cancer Patients

February 19, 2015
ST LOUIS, MO and FALLS CHURCH, VA – PierianDx announced today that the Inova Translational Medicine Institute has joined the
Read More

ARUP Introduces NGS.Web, a Powerful Next-Generation Sequencing Platform

January 21, 2015
January 21, 2015—ARUP Laboratories, a national nonprofit reference laboratory, announced today the implementation of NGS.Web, a powerful next-generation sequencing (NGS) platform. This innovative platform will enhance sample tracking, data analysis, and reporting of genetic and oncological sample testing.
Read More

PierianDx Launches NGS Gateway Program

November 17, 2014
PierianDx, the forerunner in clinical genomic informatics, announced the PDX NGS Gateway Program, a service designed to enable partner personalized medicine initiatives.
Read More

PierianDx Founder and Chief Informatics Officer, Rakesh Nagarajan publishes article describing laboratory standards for Clinical Next-Generation Sequencing

September 2, 2014
PierianDx Founder and Chief Informatics Officer, Rakesh Nagarajan publishes article describing laboratory standards for Clinical Next-Generation Sequencing. College of American Pathologists’
Read More

PierianDx Launches the Clinical Genomicist Workstation for SaaS NGS Analysis

July 23, 2014
By Allison Proffitt, Clinical Informatics News Washington University is throwing its hat in the clinical sequencing ring with a...
Read More

Moffitt Cancer Center and the University of Vermont Join PierianDx Partner Network

July 17, 2014
ST LOUIS – PierianDx announced today that Moffitt Cancer Center in Tampa, FL and Fletcher Allen...
Read More

PierianDx Licenses Diagnostic Genetic Sequencing Products from Washington University in St. Louis

June 30, 2014
ST. LOUIS, MO – PierianDx announced today that it has exclusively licensed from Washington University in St. Louis a proprietary
Read More

Journal of Molecular Diagnostics

June 1, 2014
PierianDx Medical Advisor, Catherine Cottrell, Ph.D., FACMG, publishes an article in the Journal of Molecular Diagnostics describing the validation and
Read More

Clinical NGS WUSTL

January 1, 2014
Rakesh Nagarajan, M.D., PhD., PierianDx Founder and Chief BioMedical Informatics Officer presents at the Cancer Informatics for Cancer Centers Spring 2014 Conference at the Meritage Conference Center in Napa Valley, California.
Read More